Publications by authors named "Pascal Rathelot"

Claim this Profile
C
Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients.
Laura Dubois, Cyrielle Bouguergour, Romain Paoli-Lombardo, Caroline Castera-Ducros, Christophe Jean, Pascal Rathelot

J Pharm Pharm Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixtures and dilutions of commercial solutions for oral drops: What happens in these cocktails?
Caroline Castera-Ducros, Romain Paoli-Lombardo, Ikram Zaddam, Cyril Fersing, Charleric Bornet, Pascal Rathelot

Therapie· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatrics.
Romain Paoli-Lombardo, Vincent Arcani, Delphine Dazan, Caroline Castera-Ducros, Marie-Anne Esteve, Pascal Rathelot

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Training healthcare teams of a multi-site university hospital on high-alert medication issues: Using an escape room].
Pierre Leroux, Caroline Castera-Ducros, Laurence Conreur, Said Ait Taleb, Adja Fatou Diack, Pascal Rathelot

Ann Pharm Fr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, and biotin hard gelatin capsules prepared in advance and stored for the treatment of pediatric metabolic diseases: a safer alternative.
Marine Bonino, Amélie Bouchez, Amna Kadri, Ines Jacquet, Romain Paoli-Lombardo, Pascal Rathelot

PLoS One· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel.
Edouard Lamy, Caroline Orneto, Oumil Her Abdou Ali, Lyna Kireche, Fanny Mathias, Pascal Rathelot

Pharmaceuticals (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Polio Enterovirus Inhibitors: Scaffolds, Targets, and Potency─What's New?
Hugo Fernando Georges Roux, Franck Touret, Pascal Rathelot, Pietro Sciò, Antonio Coluccia

ACS Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the "One-Molecule, One-Target, One-Disease" Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections.
Hugo Roux, Franck Touret, Pascal Rathelot, Patrice Vanelle, Manon Roche

Pharmaceuticals (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-]pyridine Antileishmanial Pharmacophore.
Romain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, Sébastien Hutter, Alix Sournia-Saquet, Pascal Rathelot

Pharmaceuticals (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates).
Thibaut Brandin, Maya Wasilewski, Camille Panuccio, Cyrielle Bouguergour, Nicolas Primas, Pascal Rathelot

Int J Pharm Compd· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties.
Cyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, Nicolas Primas, Emilie Pinault, Pascal Rathelot

Eur J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
8
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi.
Cyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, Emilie Pinault, Sébastien Hutter, Pascal Rathelot

Eur J Med Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of an elective course of pharmacist's roles in disaster management in France.
Marc Montana, Fanny Mathias, Pascal Rathelot, Jérôme Lacroix, Patrice Vanelle

J Educ Eval Health Prof· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nongenotoxic 3-Nitroimidazo[1,2-]pyridines Are NTR1 Substrates That Display Potent Antileishmanial Activity.
Cyril Fersing, Louise Basmaciyan, Clotilde Boudot, Julien Pedron, Sébastien Hutter, Pascal Rathelot

ACS Med Chem Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
8
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
Cyril Fersing, Clotilde Boudot, Julien Pedron, Sébastien Hutter, Nicolas Primas, Pascal Rathelot

Eur J Med Chem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations.
Camille Pierrisnard, Marjorie Baciuchka, Julien Mancini, Pascal Rathelot, Patrice Vanelle

Breast Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Screening of the Antibacterial and Anti-Candida Properties of Crushed Nonantimicrobial Drugs Frequently Prescribed in Nursing Homes.
Julie Lamure, Marlène Chevalier, Pascal Rathelot, Françoise Mignolet, Isabelle Precheur

Res Gerontol Nurs· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors limiting adherence to antiepileptic treatment: A French online patient survey.
Flora Laville, Marc Montana, Nicolas Roux, Pascal Rathelot, Roch Giorgi

J Clin Pharm Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold.
Justine Desroches, Charline Kieffer, Nicolas Primas, Sébastien Hutter, Armand Gellis, Pascal Rathelot

Eur J Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pertinence of Off-label Prescriptions of Innovating and Expensive Drugs in a University Hospital].
Amélie Falabregues, Marion Daul, Bertrand Pourroy, Laurence Gauthier-Villano, Pascale Pisano, Pascal Rathelot

Therapie· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Anita Cohen, Peggy Suzanne, Jean-Charles Lancelot, Pierre Verhaeghe, Aurélien Lesnard, Pascal Rathelot

Eur J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Charline Kieffer, Anita Cohen, Pierre Verhaeghe, Lucie Paloque, Sébastien Hutter, Pascal Rathelot

Bioorg Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Charline Kieffer, Anita Cohen, Pierre Verhaeghe, Sébastien Hutter, Caroline Castera-Ducros, Pascal Rathelot

Eur J Med Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[mediEVAL: a new evaluating tool for the medication-use system].
Marion Bessone, Pascal Rathelot, Raffi Agopian, Sylvie Pracchia, Etienne Schmitt

Therapie· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents.
Nicolas Primas, Peggy Suzanne, Pierre Verhaeghe, Sébastien Hutter, Charline Kieffer, Pascal Rathelot

Eur J Med Chem· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis